MASSACHUSETTS FINANCIAL SERVICES CO /MA/
Position in IMCR — Immunocore Holdings plc
CIK 912938
Boston, MA
Position in IMCR
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$12,929,203
+$646,908 QoQ
Shares Held
407,219
-0.0% QoQ
Ownership
0.791%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 136 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $2,249,676,327 across 65 Biotechnology names. IMCR ranks #23 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
1,875,301 | $500,180,281 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
2,012,317 | $376,866,725 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,049 | $210,141,127 | |
| 4 | TECH |
BIO-TECHNE Corp
|
2,746,462 | $194,037,538 | |
| 5 | SRRK |
Scholar Rock Holding Corp
|
2,607,348 | $143,404,140 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
375,762 | $118,774,610 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
350,560 | $105,529,075 | |
| 8 | BNTX |
BioNTech SE
|
677,708 | $63,060,728 |
All Filings in IMCR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,929,203 | 407,219 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $12,282,295 | 407,373 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $14,140,992 | 407,404 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $16,072,319 | 442,398 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $13,988,168 | 445,767 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $13,670,482 | 460,751 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $13,541,827 | 459,045 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $15,509,619 | 498,221 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,236,247 | 390,565 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $20,222,865 | 311,121 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $21,357,378 | 312,608 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $16,210,809 | 312,347 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $21,703,301 | 361,963 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $18,074,374 | 365,582 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $20,883,853 | 365,934 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $17,120,801 | 364,738 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $12,683,236 | 339,942 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $10,240,092 | 342,478 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $11,404,659 | 333,080 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $12,437,429 | 335,512 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,796,675 | 97,226 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,150,660 | 97,502 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||